Ionis Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 02/13/2025 | 22.69 M | $793.22 M | 0.93% | 15.27% |
| VANGUARD GROUP INC | 02/11/2025 | 16.47 M | $575.88 M | 9.41% | 11.09% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/14/2025 | 14.17 M | $495.36 M | 0.01% | 9.54% |
| BLACKROCK, INC. | 02/07/2025 | 11.67 M | $407.83 M | 7.88% | 7.85% |
| CAPITAL WORLD INVESTORS | 02/13/2025 | 11.47 M | $400.83 M | 46.46% | 7.72% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 8.67 M | $303.18 M | -0.73% | 5.84% |
| BELLEVUE GROUP AG | 02/14/2025 | 7.87 M | $275.09 M | -0.07% | 5.30% |
| STATE STREET CORP | 02/14/2025 | 5.43 M | $189.71 M | 11.88% | 3.65% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 3.83 M | $133.79 M | -9.10% | 2.58% |
| TWEEDY, BROWNE CO LLC | 02/12/2025 | 3.25 M | $113.58 M | -5.96% | 2.19% |
| ORBIMED ADVISORS LLC | 02/14/2025 | 2.82 M | $98.49 M | 21.21% | 1.90% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 2.69 M | $93.98 M | 0.71% | 1.81% |
| CITADEL ADVISORS LLC | 02/14/2025 | 2.17 M | $75.72 M | 439.93% | 1.46% |
| DEEP TRACK CAPITAL, LP | 02/14/2025 | 1.93 M | $67.61 M | -12.09% | 1.30% |
| UBS GROUP AG | 02/14/2025 | 1.92 M | $67.04 M | 1,042.25% | 1.29% |
| MACQUARIE GROUP LTD | 02/14/2025 | 1.77 M | $61.87 M | -5.35% | 1.19% |
| NORGES BANK | 02/12/2025 | 1.71 M | $59.95 M | 100.00% | 1.15% |
| CLEARBRIDGE INVESTMENTS, LLC | 02/12/2025 | 1.62 M | $56.57 M | -4.94% | 1.09% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 1.48 M | $51.79 M | 2.66% | 1.00% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 1.35 M | $47.17 M | 1.26% | 0.91% |
| MORGAN STANLEY | 02/14/2025 | 1.33 M | $46.49 M | 1.49% | 0.90% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 02/12/2025 | 1.08 M | $37.77 M | 38.55% | 0.73% |
| TD ASSET MANAGEMENT INC | 02/11/2025 | 1.05 M | $36.71 M | -3.93% | 0.71% |
| ARK INVESTMENT MANAGEMENT LLC | 02/04/2025 | 1.03 M | $35.84 M | -25.93% | 0.69% |
| GROUPAMA ASSET MANAGMENT | 02/12/2025 | 1.02 M | $18.55 M | 11.04% | 0.68% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 921,439 | $32.21 M | 0.26% | 0.62% |
| CANDRIAM S.C.A. | 02/07/2025 | 849,824 | $29.71 M | -10.38% | 0.57% |
| NORTHERN TRUST CORP | 02/14/2025 | 840,271 | $29.38 M | 13.11% | 0.57% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/14/2025 | 821,200 | $28.71 M | 7.08% | 0.55% |
| MARSHALL WACE, LLP | 02/13/2025 | 812,306 | $28.40 M | -57.70% | 0.55% |
| INVESCO LTD. | 02/13/2025 | 788,599 | $27.57 M | -2.68% | 0.53% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 774,215 | $27.07 M | 79.75% | 0.52% |
| ROYAL BANK OF CANADA | 02/14/2025 | 643,192 | $22.49 M | -4.02% | 0.43% |
| CAMBER CAPITAL MANAGEMENT LP | 02/14/2025 | 625,000 | $21.85 M | 100.00% | 0.42% |
| PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 620,798 | $21.70 M | -52.37% | 0.42% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 619,641 | $21.66 M | 116.89% | 0.42% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 616,071 | $21.54 M | 0.85% | 0.41% |
| J. GOLDMAN & CO LP | 02/14/2025 | 607,499 | $21.24 M | -0.31% | 0.41% |
| AXA S.A. | 02/14/2025 | 605,345 | $21.16 M | 7.86% | 0.41% |
| BARCLAYS PLC | 02/13/2025 | 596,072 | $20.84 M | -6.43% | 0.40% |
| VESTAL POINT CAPITAL, LP | 02/14/2025 | 595,000 | $20.80 M | 100.00% | 0.40% |
| PINNACLE ASSOCIATES LTD | 02/14/2025 | 547,642 | $19.15 M | 19.32% | 0.37% |
| GREAT POINT PARTNERS LLC | 02/14/2025 | 505,007 | $17.66 M | 98.04% | 0.34% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 422,861 | $14.78 M | -25.64% | 0.28% |
| JPMORGAN CHASE & CO | 02/12/2025 | 415,919 | $14.54 M | -26.89% | 0.28% |
| ABRDN PLC | 01/24/2025 | 401,501 | $14.03 M | 32.39% | 0.27% |
| C WORLDWIDE GROUP HOLDING A/S | 02/04/2025 | 400,000 | $13.98 M | 33.33% | 0.27% |
| AMERIPRISE FINANCIAL INC | 02/14/2025 | 387,448 | $13.54 M | -2.63% | 0.26% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 378,208 | $13.22 M | 60.45% | 0.25% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 371,381 | $12.98 M | 2.34% | 0.25% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ionis Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 501 institutional investors and hedge funds held shares of Ionis Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Castle Rock Wealth Management, LLC: 0
ROTHSCHILD INVESTMENT LLC: 0
Capital Advisors, Ltd. LLC: 0
Assenagon Asset Management S.A.: 0
FMR LLC: 22.69 M
VANGUARD GROUP INC: 16.47 M
108.34% of Ionis Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 195.63 M shares in the last 24 months. This purchase volume represents approximately $5.55 B in transactions.